CDSCO UID IMP/MD/2020/000340_d02804f6be42028bc5d9c7b832268541_9b81db96a9215a4d8a4daa8cccc6043d

Intranasal Splint 8 pack

SHREYAAS HEALTH CARE PRODUCTS PRIVATE LIMITED·Device Class Class C·India CDSCO·Brand: NexPak X
Registration details
UID
IMP/MD/2020/000340_d02804f6be42028bc5d9c7b832268541_9b81db96a9215a4d8a4daa8cccc6043d
Device class
Class C
Brand name
NexPak X
Approving authority
CDSCO
Product information
NexPak X intranasal splint is a nasal dressing intended to minimize bleeding & edema and to prevent adhesions between the septum and the nasal cavity and act as an adjunct to aid in the natural healing process post-surgical intervention. Nexpak X is constructed of a patient-comfortable sponge which is manufactured from 100% plant-based polysaccharides. NexPak is intended for use under the direction of a licensed healthcare provider.
Other products from SHREYAAS HEALTH CARE PRODUCTS PRIVATE LIMITED
Products from the same license holder (7 products)
Sterile talc
Brand: NOVATECH GSS
Class C
DUTAU NOVATECH RIGID BRONCHOSCOPE SET
Brand: NOVATECH
Class B
Tracheo-bronchial silicone stent
Brand: NOVATECH GSS
Class C
NASAL PACKING
Brand: IVALON
Class B
NASAL PACKING
Brand: CENEFOM
Class B
VOICE PROSTHESIS
Brand: Blom Singer Stomasoft Laryngectomy Tube
Class C
Laryngectomy Tube
Brand: Blom Singer Stomasoft Laryngectomy Tube
Class C
About this record

Intranasal Splint 8 pack is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2020/000340_d02804f6be42028bc5d9c7b832268541_9b81db96a9215a4d8a4daa8cccc6043d. This device is marketed under the brand name NexPak X. The license holder is SHREYAAS HEALTH CARE PRODUCTS PRIVATE LIMITED, and it is classified as Device Class Class C. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.